Trials / Unknown
UnknownNCT03394547
Pulsed Electromagnetic Field Treatment for Painful Periods
PUlsed electroMagnetic Field Treatment for Painful Periods: A Randomised Control Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Birmingham Women's NHS Foundation Trust · Other Government
- Sex
- Female
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
A single-centre, randomised controlled, double blind study comparing use of the Allay pulsed shortwave therapy treatment versus a placebo device or no treatment for management of primary dysmenorrhea.
Detailed description
Women participating in the trial will be randomly allocated to any of the three arms of the study. * Treatment for 2 menstrual cycles using the PSWT Allay device (BioElectronics Corp, Frederick USA) * Treatment for 2 menstrual cycles using a placebo device * No treatment. If they are allocated to a device both the participant and the clinician will be blinded at to weather they are using the active device or the placebo. Primary Outcome measures are: * A reduction in dysmenorrhea as measured by the highest pain score on a 10cm visual analogue scale. * A reduction in average pain score on a 10cm visual analogue scale * A reduction in use of analgesia as recorded in a pain diary * Improvement in quality of life as measured through a validated quality of life assessment tool (SF-36 questionnaire) \- Improvement in menstrual symptoms as recorded through a validated questionnaire (the Modified Menorrhagia Multi-attribute Scale (MMAS)). * Device acceptability as measured on a 5-point Likert scale ranging from "unacceptable" to "totally acceptable". * Impact upon associated cyclical symptoms as recorded in a patient symptom diary
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Allay | pulsed shortwave therapy treatment for painful periods |
| DEVICE | Placebo | A placebo device is given which is identical to the Allay device but emits no pulsed shortwave therapy. |
Timeline
- Start date
- 2017-11-03
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2018-01-09
- Last updated
- 2018-06-13
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03394547. Inclusion in this directory is not an endorsement.